Counterfeit drugs are everyone's business
Williamson, L.
Krankenpflege. Soins Infirmiers 107(7): 72-73
2014
ISSN/ISBN: 0253-0465 PMID: 25090735 Document Number: 673618
Document emailed within 1 workday
Related Documents
Williamson, L. 2014: Counterfeit drugs are everyone's business KRANKENPFLEGE. Soins Infirmiers 107(8): 22-23Sugita, M.; Miyakawa, M. 2010: Economic analysis of use of counterfeit drugs: health impairment risk of counterfeit phosphodiesterase type 5 inhibitor taken as an example Environmental Health and Preventive Medicine 15(4): 244-251
Sugita, M.; Miyakawa, M. 2010: Economic analysis of use of counterfeit drugs: health impairment risk of counterfeit phosphodiesterase type 5 inhibitor taken as an example Environmental Health and Preventive Medicine 15(4): 244-251
Amon, J.J. 2008: Dangerous medicines: unproven AIDS cures and counterfeit antiretroviral drugs Globalization and Health 4: 5
Tamir, O.; Friedman, N.; Furman-Assaf, S.; Marom, E.; Arieli, M.; Shemer, J. 2010: Counterfeit drugs in Israel and worldwide. Part I: the extent of occurrence and impending threats Harefuah 149(7): 466-469; 479
Dai, X.-m.; An, N.; Wu, J.-m.; Li, H.-y.; Zhang, Q.-m. 2010: Development and validation of HPLC-UV-MS method for the control of four anti-diabetic drugs in suspected counterfeit products Yao Xue Xue Bao 45(3): 347-352
Mole, K 2002: Street-Level Technocracy in UK Small Business Support: Business Links, Personal Business Advisers, and the Small Business Service Environment and Planning C 20(2): 179-194
Eyckmans, L. 1994: Drugs: vital necessity, illusion or business? Medecine Tropicale: Revue du Corps de Sante Colonial 54(3): 223-224
Krause, B.R. 2008: The development of novel anti-hyperlipidemic drugs: a tough business gets tougher Current Opinion in Investigational Drugs 9(9): 945-949
Benko, L.B. 2001: Healthy competition. Calif. says discounting drugs is good for business Modern Healthcare 31(48): 32
Connell, D.; Hergesheimer, C. 2014: Strengthening the Core Business of Farmers Markets through Strategic Business Planning Journal of Agriculture, Food Systems, and Community Development: 1-12
Alesi, P. 2008: Building enterprise-wide resilience by integrating business continuity capability into day-to-day business culture and technology Journal of Business Continuity and Emergency Planning 2(3): 214-220
Hahn, R. 2011: Inclusive business, human rights and the dignity of the poor: a glance beyond economic impacts of adapted business models Business Ethics: A European Review 21(1): 47-63
Moskowitz, D.B. 2000: How business coalitions simplify health care business Business and Health 18(8): 37-38; 41
Roush, W. 1997: Counterfeit chromosomes for humans Science 276(5309): 38-39
Volans, G.N. 1992: Counterfeit medicines--the case for action Adverse Drug Reactions and Toxicological Reviews 11(1): 3
Lybecker, K.M. 2004: Economics of reimportation and risks of counterfeit pharmaceuticals Managed Care 13(3 Suppl): 10-13
Hale, D.H. 2016: Pilot to Profit: Navigating Modern Business Entrepreneurship to Build your Own Business Using Online Marketing, Social Media, Content Marketing and Sales The Journal of Applied Management and Entrepreneurship 21(3): 131-132
Hale, D.H. 2016: Pilot to Profit: Navigating Modern Business Entrepreneurship to Build your Own Business Using Online Marketing, Social Media, Content Marketing and Sales The Journal of Applied Management and Entrepreneurship 21(3): 131-132
Kang, S.; Zhou, C.; He, Y.; Zhang, J.; Wei, A.-h.; Lu, J.; Ma, S.-c. 2015: Identification of Epmedii Folium and its counterfeit leaf of Quercus variabilis Zhongguo Zhong Yao Za Zhi 40(9): 1676-1680